FDA Authorizes Convalescent Plasma As Emergency Treatment For COVID-19
President Trump announced on Sunday that the FDA granted emergency use authorization to treat COVID-19 patients with plasma from people who have recovered from the virus, based on "promising" results.
by Rachel Treisman
Aug 23, 2020
2 minutes
President Trump announced on Sunday that the Food and Drug Administration has issued emergency use authorization to treat hospitalized COVID-19 patients with convalescent plasma from people who have recovered from the virus.
Joined by Health and Human Services Secretary Alex Azar and FDA Commissioner Stephen Hahn
You’re reading a preview, subscribe to read more.
Start your free 30 days